FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagelt.hl7.fhir.prostate
Resource TypeCodeSystem
IdCodeSystem-prostate-questionnaire-options.json
FHIR VersionR5
Sourcehttps://build.fhir.org/ig/HL7LT/ig-lt-prostate/CodeSystem-prostate-questionnaire-options.html
URLhttps://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options
Version0.0.1
Statusdraft
Date2026-03-31T08:54:25+00:00
NameProstateQuestionnaireOptions
TitleProstate questionnaire answer options (illustrative)
DescriptionIllustrative codes for **Questionnaire** answer options for prostate ESPBI-style forms in this IG. Register or replace with national coded values in production.
Contentcomplete

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source


English


Generated Narrative: CodeSystem prostate-questionnaire-options

Language: en

This case-sensitive code system https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options defines the following codes:

CodeDisplay
specimen-satisfactory Specimen satisfactory for evaluation
specimen-limited Specimen satisfactory but limited
specimen-insufficient Insufficient tissue for diagnosis
treatment-unknown Treatment effect unknown
treatment-unidentifiable Treatment effect unidentifiable
treatment-radiotherapy Observed radiotherapy effect
treatment-hormone Observed hormone therapy effect
treatment-other Observed other therapy effect
hist-acinar Acinar adenocarcinoma (conventional)
hist-acinar-signet-ring Acinar adenocarcinoma, signet-ring cell-like
hist-acinar-pleomorphic Acinar adenocarcinoma, pleomorphic giant cell
hist-acinar-sarcomatoid Acinar adenocarcinoma, sarcomatoid
hist-acinar-pin-like Acinar adenocarcinoma, PIN-like
hist-idc-isolated Isolated intraductal carcinoma
hist-ductal Ductal adenocarcinoma
hist-adenosquamous Adenosquamous carcinoma
hist-squamous Squamous cell carcinoma
hist-basal-cell Basal cell (adenoid cystic) carcinoma
hist-neuro-adeno Adenocarcinoma with neuroendocrine differentiation
hist-neuro-well-diff Well-differentiated neuroendocrine tumor
hist-neuro-small-cell Small cell neuroendocrine carcinoma
hist-neuro-large-cell Large cell neuroendocrine carcinoma
hist-unassessable Carcinoma, type unassessable
hist-other Other histological type (see comment)
isup-gg1 ISUP Grade Group 1 (Gleason 3+3)
isup-gg2 ISUP Grade Group 2 (Gleason 3+4)
isup-gg3 ISUP Grade Group 3 (Gleason 4+3)
isup-gg4 ISUP Grade Group 4 (Gleason 4+4 or equivalent)
isup-gg5 ISUP Grade Group 5 (Gleason 4+5 / 5+4 / 5+5)
idc-absent Intraductal carcinoma not identified
idc-present Intraductal carcinoma identifiable
cribriform-na Cribriform not applicable
cribriform-unknown Cribriform undefined
cribriform-present Cribriform identifiable
dre-not-done DRE not performed
dre-normal DRE normal
dre-suspicious DRE suspicious
referral-screening Referral for screening
referral-elevated-psa Referral for elevated PSA
referral-other Other referral reason
ynk-yes Yes
ynk-no No
ynk-unknown Unknown
pirads-cat-1-2 PI-RADS 1–2
pirads-cat-3 PI-RADS 3
pirads-cat-4 PI-RADS 4
pirads-cat-5 PI-RADS 5
pattern4-pct-na Pattern 4 %: not applicable
pattern4-pct-lte5 Pattern 4 %: ≤5%
pattern4-pct-6-10 Pattern 4 %: 6–10%
pattern4-pct-gt40 Pattern 4 %: >40%
tumor-pct-lt1 Tumour % in biopsy: <1%
tumor-pct-1-5 Tumour % in biopsy: 1–5%
tumor-pct-gt90 Tumour % in biopsy: >90%
tumor-pct-uneval Tumour %: cannot be evaluated
periprostatic-unknown Periprostatic fat invasion: unidentifiable
periprostatic-absent Periprostatic fat invasion: not identified
periprostatic-present Periprostatic fat invasion: present
biopsy-initial Initial biopsy
biopsy-repeat Repeat biopsy
fixative-buffered-formalin 10% buffered formalin
fixative-unfixed Unfixed (no fixative)
dx-n40-gph N40 Glandular prostatic hyperplasia
dx-c61 C61 Malignant neoplasm of prostate
ct-1c cT1c
ct-2 cT2
ct-3a cT3a
ct-3b cT3b
op-transperineal Transperineal biopsy
op-transrectal Transrectal biopsy
proc-systematic Systematic biopsy
proc-adaptive Adaptive biopsy
proc-systematic-targeted Systematic + targeted biopsy
proc-applicative-perifocal Applicative + perifocal biopsy
perineural-present Perineural invasion present
perineural-absent Perineural invasion not identified
perineural-ambiguous Perineural invasion ambiguous
perineural-uneval Perineural invasion cannot be evaluated
lymphovascular-present Lymphovascular invasion identifiable
lymphovascular-absent Lymphovascular invasion unidentifiable / not available
lymphovascular-ambiguous Lymphovascular invasion ambiguous
lymphovascular-uneval Lymphovascular invasion cannot be evaluated

Lithuanian


Generated Narrative: CodeSystem prostate-questionnaire-options

Language: en

This case-sensitive code system https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options defines the following codes:

CodeDisplay
specimen-satisfactory Specimen satisfactory for evaluation
specimen-limited Specimen satisfactory but limited
specimen-insufficient Insufficient tissue for diagnosis
treatment-unknown Treatment effect unknown
treatment-unidentifiable Treatment effect unidentifiable
treatment-radiotherapy Observed radiotherapy effect
treatment-hormone Observed hormone therapy effect
treatment-other Observed other therapy effect
hist-acinar Acinar adenocarcinoma (conventional)
hist-acinar-signet-ring Acinar adenocarcinoma, signet-ring cell-like
hist-acinar-pleomorphic Acinar adenocarcinoma, pleomorphic giant cell
hist-acinar-sarcomatoid Acinar adenocarcinoma, sarcomatoid
hist-acinar-pin-like Acinar adenocarcinoma, PIN-like
hist-idc-isolated Isolated intraductal carcinoma
hist-ductal Ductal adenocarcinoma
hist-adenosquamous Adenosquamous carcinoma
hist-squamous Squamous cell carcinoma
hist-basal-cell Basal cell (adenoid cystic) carcinoma
hist-neuro-adeno Adenocarcinoma with neuroendocrine differentiation
hist-neuro-well-diff Well-differentiated neuroendocrine tumor
hist-neuro-small-cell Small cell neuroendocrine carcinoma
hist-neuro-large-cell Large cell neuroendocrine carcinoma
hist-unassessable Carcinoma, type unassessable
hist-other Other histological type (see comment)
isup-gg1 ISUP Grade Group 1 (Gleason 3+3)
isup-gg2 ISUP Grade Group 2 (Gleason 3+4)
isup-gg3 ISUP Grade Group 3 (Gleason 4+3)
isup-gg4 ISUP Grade Group 4 (Gleason 4+4 or equivalent)
isup-gg5 ISUP Grade Group 5 (Gleason 4+5 / 5+4 / 5+5)
idc-absent Intraductal carcinoma not identified
idc-present Intraductal carcinoma identifiable
cribriform-na Cribriform not applicable
cribriform-unknown Cribriform undefined
cribriform-present Cribriform identifiable
dre-not-done DRE not performed
dre-normal DRE normal
dre-suspicious DRE suspicious
referral-screening Referral for screening
referral-elevated-psa Referral for elevated PSA
referral-other Other referral reason
ynk-yes Yes
ynk-no No
ynk-unknown Unknown
pirads-cat-1-2 PI-RADS 1–2
pirads-cat-3 PI-RADS 3
pirads-cat-4 PI-RADS 4
pirads-cat-5 PI-RADS 5
pattern4-pct-na Pattern 4 %: not applicable
pattern4-pct-lte5 Pattern 4 %: ≤5%
pattern4-pct-6-10 Pattern 4 %: 6–10%
pattern4-pct-gt40 Pattern 4 %: >40%
tumor-pct-lt1 Tumour % in biopsy: <1%
tumor-pct-1-5 Tumour % in biopsy: 1–5%
tumor-pct-gt90 Tumour % in biopsy: >90%
tumor-pct-uneval Tumour %: cannot be evaluated
periprostatic-unknown Periprostatic fat invasion: unidentifiable
periprostatic-absent Periprostatic fat invasion: not identified
periprostatic-present Periprostatic fat invasion: present
biopsy-initial Initial biopsy
biopsy-repeat Repeat biopsy
fixative-buffered-formalin 10% buffered formalin
fixative-unfixed Unfixed (no fixative)
dx-n40-gph N40 Glandular prostatic hyperplasia
dx-c61 C61 Malignant neoplasm of prostate
ct-1c cT1c
ct-2 cT2
ct-3a cT3a
ct-3b cT3b
op-transperineal Transperineal biopsy
op-transrectal Transrectal biopsy
proc-systematic Systematic biopsy
proc-adaptive Adaptive biopsy
proc-systematic-targeted Systematic + targeted biopsy
proc-applicative-perifocal Applicative + perifocal biopsy
perineural-present Perineural invasion present
perineural-absent Perineural invasion not identified
perineural-ambiguous Perineural invasion ambiguous
perineural-uneval Perineural invasion cannot be evaluated
lymphovascular-present Lymphovascular invasion identifiable
lymphovascular-absent Lymphovascular invasion unidentifiable / not available
lymphovascular-ambiguous Lymphovascular invasion ambiguous
lymphovascular-uneval Lymphovascular invasion cannot be evaluated

Source1

{
  "resourceType": "CodeSystem",
  "id": "prostate-questionnaire-options",
  "language": "en",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "url": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
  "version": "0.0.1",
  "name": "ProstateQuestionnaireOptions",
  "title": "Prostate questionnaire answer options (illustrative)",
  "status": "draft",
  "experimental": true,
  "date": "2026-03-31T08:54:25+00:00",
  "publisher": "Lithuanian Medical Library",
  "contact": [
    {
      "name": "Lithuanian Medical Library",
      "telecom": [
        {
          "system": "url",
          "value": "https://medicinosnk.lt"
        },
        {
          "system": "email",
          "value": "info@medicinosnk.lt"
        }
      ]
    }
  ],
  "description": "Illustrative codes for **Questionnaire** answer options for prostate ESPBI-style forms in this IG. Register or replace with national coded values in production.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "LT"
        }
      ]
    }
  ],
  "caseSensitive": true,
  "content": "complete",
  "count": 82,
  "concept": [
    {
      "code": "specimen-satisfactory",
      "display": "Specimen satisfactory for evaluation"
    },
    {
      "code": "specimen-limited",
      "display": "Specimen satisfactory but limited"
    },
    {
      "code": "specimen-insufficient",
      "display": "Insufficient tissue for diagnosis"
    },
    {
      "code": "treatment-unknown",
      "display": "Treatment effect unknown"
    },
    {
      "code": "treatment-unidentifiable",
      "display": "Treatment effect unidentifiable"
    },
    {
      "code": "treatment-radiotherapy",
      "display": "Observed radiotherapy effect"
    },
    {
      "code": "treatment-hormone",
      "display": "Observed hormone therapy effect"
    },
    {
      "code": "treatment-other",
      "display": "Observed other therapy effect"
    },
    {
      "code": "hist-acinar",
      "display": "Acinar adenocarcinoma (conventional)"
    },
    {
      "code": "hist-acinar-signet-ring",
      "display": "Acinar adenocarcinoma, signet-ring cell-like"
    },
    {
      "code": "hist-acinar-pleomorphic",
      "display": "Acinar adenocarcinoma, pleomorphic giant cell"
    },
    {
      "code": "hist-acinar-sarcomatoid",
      "display": "Acinar adenocarcinoma, sarcomatoid"
    },
    {
      "code": "hist-acinar-pin-like",
      "display": "Acinar adenocarcinoma, PIN-like"
    },
    {
      "code": "hist-idc-isolated",
      "display": "Isolated intraductal carcinoma"
    },
    {
      "code": "hist-ductal",
      "display": "Ductal adenocarcinoma"
    },
    {
      "code": "hist-adenosquamous",
      "display": "Adenosquamous carcinoma"
    },
    {
      "code": "hist-squamous",
      "display": "Squamous cell carcinoma"
    },
    {
      "code": "hist-basal-cell",
      "display": "Basal cell (adenoid cystic) carcinoma"
    },
    {
      "code": "hist-neuro-adeno",
      "display": "Adenocarcinoma with neuroendocrine differentiation"
    },
    {
      "code": "hist-neuro-well-diff",
      "display": "Well-differentiated neuroendocrine tumor"
    },
    {
      "code": "hist-neuro-small-cell",
      "display": "Small cell neuroendocrine carcinoma"
    },
    {
      "code": "hist-neuro-large-cell",
      "display": "Large cell neuroendocrine carcinoma"
    },
    {
      "code": "hist-unassessable",
      "display": "Carcinoma, type unassessable"
    },
    {
      "code": "hist-other",
      "display": "Other histological type (see comment)"
    },
    {
      "code": "isup-gg1",
      "display": "ISUP Grade Group 1 (Gleason 3+3)"
    },
    {
      "code": "isup-gg2",
      "display": "ISUP Grade Group 2 (Gleason 3+4)"
    },
    {
      "code": "isup-gg3",
      "display": "ISUP Grade Group 3 (Gleason 4+3)"
    },
    {
      "code": "isup-gg4",
      "display": "ISUP Grade Group 4 (Gleason 4+4 or equivalent)"
    },
    {
      "code": "isup-gg5",
      "display": "ISUP Grade Group 5 (Gleason 4+5 / 5+4 / 5+5)"
    },
    {
      "code": "idc-absent",
      "display": "Intraductal carcinoma not identified"
    },
    {
      "code": "idc-present",
      "display": "Intraductal carcinoma identifiable"
    },
    {
      "code": "cribriform-na",
      "display": "Cribriform not applicable"
    },
    {
      "code": "cribriform-unknown",
      "display": "Cribriform undefined"
    },
    {
      "code": "cribriform-present",
      "display": "Cribriform identifiable"
    },
    {
      "code": "dre-not-done",
      "display": "DRE not performed"
    },
    {
      "code": "dre-normal",
      "display": "DRE normal"
    },
    {
      "code": "dre-suspicious",
      "display": "DRE suspicious"
    },
    {
      "code": "referral-screening",
      "display": "Referral for screening"
    },
    {
      "code": "referral-elevated-psa",
      "display": "Referral for elevated PSA"
    },
    {
      "code": "referral-other",
      "display": "Other referral reason"
    },
    {
      "code": "ynk-yes",
      "display": "Yes"
    },
    {
      "code": "ynk-no",
      "display": "No"
    },
    {
      "code": "ynk-unknown",
      "display": "Unknown"
    },
    {
      "code": "pirads-cat-1-2",
      "display": "PI-RADS 1–2"
    },
    {
      "code": "pirads-cat-3",
      "display": "PI-RADS 3"
    },
    {
      "code": "pirads-cat-4",
      "display": "PI-RADS 4"
    },
    {
      "code": "pirads-cat-5",
      "display": "PI-RADS 5"
    },
    {
      "code": "pattern4-pct-na",
      "display": "Pattern 4 %: not applicable"
    },
    {
      "code": "pattern4-pct-lte5",
      "display": "Pattern 4 %: ≤5%"
    },
    {
      "code": "pattern4-pct-6-10",
      "display": "Pattern 4 %: 6–10%"
    },
    {
      "code": "pattern4-pct-gt40",
      "display": "Pattern 4 %: >40%"
    },
    {
      "code": "tumor-pct-lt1",
      "display": "Tumour % in biopsy: <1%"
    },
    {
      "code": "tumor-pct-1-5",
      "display": "Tumour % in biopsy: 1–5%"
    },
    {
      "code": "tumor-pct-gt90",
      "display": "Tumour % in biopsy: >90%"
    },
    {
      "code": "tumor-pct-uneval",
      "display": "Tumour %: cannot be evaluated"
    },
    {
      "code": "periprostatic-unknown",
      "display": "Periprostatic fat invasion: unidentifiable"
    },
    {
      "code": "periprostatic-absent",
      "display": "Periprostatic fat invasion: not identified"
    },
    {
      "code": "periprostatic-present",
      "display": "Periprostatic fat invasion: present"
    },
    {
      "code": "biopsy-initial",
      "display": "Initial biopsy"
    },
    {
      "code": "biopsy-repeat",
      "display": "Repeat biopsy"
    },
    {
      "code": "fixative-buffered-formalin",
      "display": "10% buffered formalin"
    },
    {
      "code": "fixative-unfixed",
      "display": "Unfixed (no fixative)"
    },
    {
      "code": "dx-n40-gph",
      "display": "N40 Glandular prostatic hyperplasia"
    },
    {
      "code": "dx-c61",
      "display": "C61 Malignant neoplasm of prostate"
    },
    {
      "code": "ct-1c",
      "display": "cT1c"
    },
    {
      "code": "ct-2",
      "display": "cT2"
    },
    {
      "code": "ct-3a",
      "display": "cT3a"
    },
    {
      "code": "ct-3b",
      "display": "cT3b"
    },
    {
      "code": "op-transperineal",
      "display": "Transperineal biopsy"
    },
    {
      "code": "op-transrectal",
      "display": "Transrectal biopsy"
    },
    {
      "code": "proc-systematic",
      "display": "Systematic biopsy"
    },
    {
      "code": "proc-adaptive",
      "display": "Adaptive biopsy"
    },
    {
      "code": "proc-systematic-targeted",
      "display": "Systematic + targeted biopsy"
    },
    {
      "code": "proc-applicative-perifocal",
      "display": "Applicative + perifocal biopsy"
    },
    {
      "code": "perineural-present",
      "display": "Perineural invasion present"
    },
    {
      "code": "perineural-absent",
      "display": "Perineural invasion not identified"
    },
    {
      "code": "perineural-ambiguous",
      "display": "Perineural invasion ambiguous"
    },
    {
      "code": "perineural-uneval",
      "display": "Perineural invasion cannot be evaluated"
    },
    {
      "code": "lymphovascular-present",
      "display": "Lymphovascular invasion identifiable"
    },
    {
      "code": "lymphovascular-absent",
      "display": "Lymphovascular invasion unidentifiable / not available"
    },
    {
      "code": "lymphovascular-ambiguous",
      "display": "Lymphovascular invasion ambiguous"
    },
    {
      "code": "lymphovascular-uneval",
      "display": "Lymphovascular invasion cannot be evaluated"
    }
  ]
}